November 15, 2019 / 7:25 AM / a month ago

BRIEF-iApotek Int Decides On Directed Offset Issue

Nov 15 (Reuters) - iApotek Int AB:

* SAID ON THURSDAY DECIDED ON A DIRECTED OFFSET ISSUE IN CONNECTION WITH PAYMENT OF ADDITIONAL PURCHASE PRICE REGARDING THE ACQUISITION OF EPRIX AB

* 473,260 SHARES WILL BE ISSUED AT THE PRICE OF SEK 2.111003

* THE SUBSCRIPTION PRICE FOR XIRPE AB (THE SELLER OF EPRIX AB) HAS BEEN DETERMINED IN ACCORDANCE WITH THE TERMS OF THE SHARE TRANSFER AGREEMENT ON WHICH THE ACQUISITION IS BASED

* THE ISSUE COSTS ARE ESTIMATED TO AMOUNT TO ABOUT SEK 15,000

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below